A rapid ultra HPLC-MS/MS method for the quantitation and pharmacokinetic analysis of 3-deazaneplanocin A in mice

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 927, Issue , 2013, Pages 142-146

  Peer, Cody J ^a   Rao, Mahadev ^a   Spencer, Shawn D ^b   Shahbazi, Shandiz ^a   Steeg, Patricia S ^a   Schrump, David S ^a   Figg, William D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FAIRLEIGH DICKINSON UNIVERSITY   (United States)

Author keywords

3 Deazaneplanocin; Pharmacokinetics; Ultra HPLC MS MS

Indexed keywords

3-DEAZANEPLANOCIN; ANTICANCER ACTIVITIES; LIMIT OF QUANTITATIONS; LIQUID-LIQUID EXTRACTION PROCEDURE; PHARMACOKINETIC ANALYSIS; PHARMACOKINETIC STUDIES; TANDEM MASS SPECTROMETRIC; ULTRA HPLC-MS/MS;

DISEASES; MAMMALS;

PHARMACOKINETICS;

3 DEAZANEPLANOCIN A; TUBERCIDIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; HYDROPHILICITY; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MEASUREMENT ACCURACY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAPID TEST; REFERENCE VALUE; STANDARD; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADENOSINE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; LEAST-SQUARES ANALYSIS; LIQUID-LIQUID EXTRACTION; MICE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TUBERCIDIN;

MUS;

EID: 84876959022     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.01.003     Document Type: Article

References (26)

1. Baylin S.B., Ohm J.E. Nat. Rev. Cancer 2006, 6:107.
2. Feinberg A.P., Tycko B. Nat. Rev. Cancer 2004, 4:143.
3. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K., Iyer N.G., Perez-Rosado A., Calvo E., Lopez J.A., Cano A., Calasanz M.J., Colomer D., Piris M.A., Ahn N., Imhof A., Caldas C., Jenuwein T., Esteller M. Nat. Genet. 2005, 37:391.
4. Jones P.A., Baylin S.B. Nat. Rev. Genet. 2002, 3:415.
5. Miranda T.B., Jones P.A. J. Cell. Physiol. 2007, 213:384.
6. Gal-Yam E.N., Egger G., Iniguez L., Holster H., Einarsson S., Zhang X., Lin J.C., Liang G., Jones P.A., Tanay A. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12979.
7. Kondo Y., Shen L., Cheng A.S., Ahmed S., Boumber Y., Charo C., Yamochi T., Urano T., Furukawa K., Kwabi-Addo B., Gold D.L., Sekido Y., Huang T.H., Issa J.P. Nat. Genet. 2008, 40:741.
8. Sparmann A., van Lohuizen M. Nat. Rev. Cancer 2006, 6:846.
9. Takawa M., Masuda K., Kunizaki M., Daigo Y., Takagi K., Iwai Y., Cho H.S., Toyokawa G., Yamane Y., Maejima K., Field H.I., Kobayashi T., Akasu T., Sugiyama M., Tsuchiya E., Atomi Y., Ponder B.A., Nakamura Y., Hamamoto R. Cancer Sci. 2011, 102:1298.
10. Bachmann I.M., Halvorsen O.J., Collett K., Stefansson I.M., Straume O., Haukaas S.A., Salvesen H.B., Otte A.P., Akslen L.A. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2006, 24:268.
11. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., Sabel M.S., Livant D., Weiss S.J., Rubin M.A., Chinnaiyan A.M. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11606.
12. Matsukawa Y., Semba S., Kato H., Ito A., Yanagihara K., Yokozaki H. Cancer Sci. 2006, 97:484.
13. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., Chinnaiyan A.M. Nature 2002, 419:624.
14. Wagener N., Macher-Goeppinger S., Pritsch M., Husing J., Hoppe-Seyler K., Schirmacher P., Pfitzenmaier J., Haferkamp A., Hoppe-Seyler F., Hohenfellner M. BMC Cancer 2010, 10:524.
15. Kemp C.D., Rao M., Xi S., Inchauste S., Mani H., Fetsch P., Filie A., Zhang M., Hong J.A., Walker R.L., Zhu Y.J., Ripley R.T., Mathur A., Liu F., Yang M., Meltzer P.A., Marquez V.E., De Rienzo A., Bueno R., Schrump D.S. Clin. Cancer Res. 2012, 18:77.
16. Karanikolas B.D., Figueiredo M.L., Wu L. The Prostate 2010, 70:675.
17. Ougolkov A.V., Bilim V.N., Billadeau D.D. Clin. Cancer Res. 2008, 14:6790.
18. Wagener N., Holland D., Bulkescher J., Crnkovic-Mertens I., Hoppe-Seyler K., Zentgraf H., Pritsch M., Buse S., Pfitzenmaier J., Haferkamp A., Hohenfellner M., Hoppe-Seyler F. Int. J. Cancer 2008, 123:1545.
19. Miranda T.B., Cortez C.C., Yoo C.B., Liang G., Abe M., Kelly T.K., Marquez V.E., Jones P.A. Mol. Cancer Ther. 2009, 8:1579.
20. Crea F., Hurt E.M., Mathews L.A., Cabarcas S.M., Sun L., Marquez V.E., Danesi R., Farrar W.L. Mol. Cancer 2011, 10:40.
21. Fiskus W., Wang Y., Sreekumar A., Buckley K.M., Shi H., Jillella A., Ustun C., Rao R., Fernandez P., Chen J., Balusu R., Koul S., Atadja P., Marquez V.E., Bhalla K.N. Blood 2009, 114:2733.
22. Hayden A., Johnson P.W., Packham G., Crabb S.J. Breast Cancer Res. Treat. 2010, 127:109.
23. Coulombe R.A., Sharma R.P., Huggins J.W. Eur. Drug Metab. Pharmacokinet. 1995, 20:197.
24. Sun F., Li J., Yu Q., Chan E. Eur. J. Pharm. Biopharm. 2012, 80:323.
25. Sun F., Ong J.C., Yu Q., Chan E. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2011, 879:285.
26. Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation 2001.